874
Participants
Start Date
June 30, 2009
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Desvenlafaxine succinate sustained release 50 mg
50 mg tablet, once daily. 5 months open-label duration for all enrolled subjects; additional 6 months double-blind duration for randomized subjects assigned to this arm.
Desvenlafaxine succinate sustained release 25 mg
25 mg tablet for taper, once daily for 1 week
Placebo
Matching placebo tablet, once daily. 6 months double-blind duration for randomized subjects assigned to placebo.
Pfizer Investigational Site, Kaunas
Pfizer Investigational Site, Durban
Pfizer Investigational Site, Strenči
Pfizer Investigational Site, Strenči
Pfizer Investigational Site, Cape Town
Pfizer Investigational Site, Paarl
Pfizer Investigational Site, Zagreb
Pfizer Investigational Site, New York
Pfizer Investigational Site, New York
Pfizer Investigational Site, Vilnius
Pfizer Investigational Site, Tallinn
Pfizer Investigational Site, Caen
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Turku
Pfizer Investigational Site, Rockville
Pfizer Investigational Site, Smyrna
Pfizer Investigational Site, Atlanta
Pfizer Investigational Site, Jacksonville
Pfizer Investigational Site, Tampere
Pfizer Investigational Site, South Miami
Pfizer Investigational Site, St. Petersburg
Pfizer Investigational Site, St. Petersburg
Pfizer Investigational Site, Rennes
Pfizer Investigational Site, Dole
Pfizer Investigational Site, Orvault
Pfizer Investigational Site, Dayton
Pfizer Investigational Site, Rijeka
Pfizer Investigational Site, Tartu
Pfizer Investigational Site, Douai
Pfizer Investigational Site, Douai
Pfizer Investigational Site, Seinäjoki
Pfizer Investigational Site, Hoffman Estates
Pfizer Investigational Site, Võru
Pfizer Investigational Site, Vöru
Pfizer Investigational Site, Kuopio
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Joensuu
Pfizer Investigational Site, Beverly Hills
Pfizer Investigational Site, Los Alamitos
Pfizer Investigational Site, Trenčín
Pfizer Investigational Site, Encino
Pfizer Investigational Site, Upland
Pfizer Investigational Site, Orange
Pfizer Investigational Site, Portland
Pfizer Investigational Site, Seattle
Pfizer Investigational Site, Craiova
Pfizer Investigational Site, Cluj-Napoca
Pfizer Investigational Site, Brasov
Pfizer Investigational Site, Santiago
Pfizer Investigational Site, Santiago
Pfizer Investigational Site, Santiago
Pfizer Investigational Site, Edmonton
Pfizer Investigational Site, Medicine Hat
Pfizer Investigational Site, Kelowna
Pfizer Investigational Site, Vancouver
Pfizer Investigational Site, Bathurst
Pfizer Investigational Site, Burlington
Pfizer Investigational Site, Ottawa
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Gatineau
Pfizer Investigational Site, Pointe-Claire
Pfizer Investigational Site, Sherbrooke
Pfizer Investigational Site, Medellín
Pfizer Investigational Site, Barranquilla
Pfizer Investigational Site, Bogota
Pfizer Investigational Site, Bucamaranga
Pfizer Investigational Site, Tallinn
Pfizer Investigational Site, Sigulda
Pfizer Investigational Site, Vilius
Pfizer Investigational Site, Espoo
Pfizer Investigational Site, Helsinki
Pfizer Investigational Site, Liepāja
Pfizer Investigational Site, Sigulda
Pfizer Investigational Site, Kaunas
Pfizer Investigational Site, Vilnius
Pfizer Investigational Site, Vilnius
Pfizer Investigational Site, Skorzewo
Pfizer Investigational Site, Szczecin
Pfizer Investigational Site, Torun
Pfizer Investigational Site, Tuszyn
Pfizer Investigational Site, Wroclaw
Pfizer Investigational Site, Żuromin
Pfizer Investigational Site, Bucharest
Pfizer Investigational Site, Bucharest
Pfizer Investigational Site, Bojnice
Pfizer Investigational Site, Bratislava
Pfizer Investigational Site, Liptovský Mikuláš
Pfizer Investigational Site, Michalovce
Pfizer Investigational Site, Rimavská Sobota
Lead Sponsor
Pfizer
INDUSTRY